CD8+ T cells from ITP patients were divided into four groups, including control, anti-human PD-1 antibody (Anti-hPD-1), 100 nM decitabine, and anti-hPD-1 combined with 100 nM decitabine. The gene discussed is CD8A; the disease is autoimmune thrombocytopenic purpura.